Follow
Vijayendra Dasari
Vijayendra Dasari
Research Offiecr
Verified email at qimrberghofer.edu.au
Title
Cited by
Cited by
Year
Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma
A Schuessler, C Smith, L Beagley, GM Boyle, S Rehan, K Matthews, ...
Cancer research 74 (13), 3466-3476, 2014
1982014
Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases
V Dasari, C Smith, R Khanna
Expert review of vaccines 12 (6), 661-676, 2013
492013
Autophagy and proteasome interconnect to coordinate cross‐presentation through MHC class I pathway in B cells
V Dasari, S Rehan, SK Tey, MJ Smyth, C Smith, R Khanna
Immunology and Cell Biology 94 (10), 964-974, 2016
392016
Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of …
V Dasari, C Smith, J Zhong, G Scott, W Rawlinson, R Khanna
Journal of general virology 92 (5), 1021-1031, 2011
382011
Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells
C Smith, D Elhassen, S Gras, KK Wynn, V Dasari, J Tellam, SK Tey, ...
Blood, The Journal of the American Society of Hematology 120 (16), 3237-3245, 2012
352012
Prophylactic and therapeutic strategies for Epstein–Barr virus-associated diseases: emerging strategies for clinical development
V Dasari, D Sinha, MA Neller, C Smith, R Khanna
Expert review of vaccines 18 (5), 457-474, 2019
332019
Impaired Epstein-Barr virus-specific neutralizing antibody response during acute infectious mononucleosis is coincident with global B-cell dysfunction
A Panikkar, C Smith, A Hislop, N Tellam, V Dasari, KA Hogquist, M Wykes, ...
Journal of virology 89 (17), 9137-9141, 2015
302015
Cytokine-mediated loss of blood dendritic cells during Epstein-Barr virus–associated acute infectious mononucleosis: Implication for immune dysregulation
A Panikkar, C Smith, A Hislop, N Tellam, V Dasari, KA Hogquist, M Wykes, ...
The Journal of infectious diseases 212 (12), 1957-1961, 2015
292015
Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities
V Dasari, KH Bhatt, C Smith, R Khanna
Expert Review of Vaccines 16 (4), 377-390, 2017
262017
Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients
V Dasari, A Schuessler, C Smith, Y Wong, JJ Miles, MJ Smyth, ...
Molecular Therapy-Methods & Clinical Development 3, 2016
162016
Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunity
V Dasari, C Smith, A Schuessler, J Zhong, R Khanna
Human vaccines & immunotherapeutics 10 (4), 1064-1077, 2014
122014
Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients
K Hardy, C Smith, WJ Tu, R McCuaig, A Panikkar, V Dasari, F Wu, SK Tey, ...
Blood advances 2 (6), 656-668, 2018
52018
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice
V Dasari, LK McNeil, K Beckett, M Solomon, G Ambalathingal, TL Thuy, ...
Nature Communications 14 (1), 4371, 2023
32023
A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice
V Dasari, K Beckett, S Horsefield, G Ambalathingal, R Khanna
PLoS Pathogens 18 (6), e1010403, 2022
32022
Human cytomegalovirus polyepitope vaccine composition
R Khana, V Dasari
US Patent App. 17/921,945, 2023
2023
Multivirus-specific t cell immunotherapy
R Khanna, V Dasari
US Patent App. 17/886,270, 2023
2023
PROTEIN FOR IMPROVED HUMAN HERPESVIRUS IMMUNOTHERAPY
D KHANNA, Rajiv and VIJAYENDRA
JP Patent 7,110,302, 2022
2022
A Lymph Node Targeted Adjuvant and Engineered Subunit Vaccine Promotes Potent Immunity to Epstein-Barr Virus in HLA-expressing Mice
V Dasari, L McNeil, K Beckett, M Solomon, G Ambalathingal, M Steinbuck, ...
2022
Multivirus-specific t cell immunotherapy
R Khanna, V Dasari
US Patent App. 16/318,555, 2021
2021
MULTIVIRUS-SPECIFIC T-LYMPHOCYTES IMMUNOTHERAPY
R Khanna, V Dasari
2020
The system can't perform the operation now. Try again later.
Articles 1–20